Source: iQoncept / Shutterstock
MyMD Pharmaceuticals (NASDAQ:MYMD) just reported results for the fourth quarter of 2023.
- MyMD Pharmaceuticals reported earnings per share of -$5.14.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/mymd-stock-earnings-mymd-pharmaceuticals-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC